The effects of peritoneal dialysis on blood glutamate levels: Implementation for neuroprotection

Journal of Neurosurgical Anesthesiology

Volumn 25, Issue 3, 2013, Pages 262-266

  Rogachev, Boris ^a   Tsesis, Svetlana ^b   Gruenbaum, Benjamin F ^b   Gruenbaum, Shaun E ^c   Boyko, Matthew ^b   Klein, Moti ^b   Shapira, Yoram ^b   Vorobiev, Marina ^a   Zlotnik, Alexander ^b  

^a Department of Nephrology ^*  (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain injury; glutamate; glutamate oxaloacetate transaminase (GOT); glutamate pyruvate transaminase (GPT); peritoneal dialysis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; DIALYSIS FLUID; GLUCOSE; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; UREA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BRAIN INJURY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROPROTECTION; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PH; PRIORITY JOURNAL; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BICARBONATES; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CREATININE; FEMALE; GLUTAMIC ACID; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PERITONEAL DIALYSIS;

EID: 84880024217     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e318283f86a     Document Type: Article

References (29)

1. Castillo J, Davalos A, Naveiro J, et al. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060-1065.
2. Castillo J, Davalos A, Noya M. Progression ofischaemic stroke and excitotoxic aminoacids. Lancet. 1997;349:79-83.
3. Johnston MV, Trescher WH, Ishida A, et al. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res. 2001; 49:735-741.
4. Zauner A, Bullock R, Kuta AJ, et al. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl. 1996;67:40-44.
5. Campos F, Sobrino T, Ramos-Cabrer P, et al. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke. J Cereb Blood Flow Metab. 2011;31:1387-1393.
6. Campos F, Sobrino T, Ramos-Cabrer P, et al. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab. 2011;31: 1378-1386.
7. Campos F, Rodriguez-Yanez M, Castellanos M, et al. Blood levels of glutamate oxaloacetate transaminase are stronger associated with good outcome in acute ishcemic stroke than glutamate pyruvate transaminase. Clin Sci (Lond). 2011;121:11-17.
8. Aliprandi A, Longoni M, Stanzani L, et al. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab. 2005;25:513-519.
9. O'Kane RL, Martinez-Lopez I, DeJoseph MR, et al. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem. 1999;274:31891-31895.
10. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, et al. Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience. 2009;158:301-308.
11. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
12. Berl S, Lajtha A, Waelsch H. Amino acid and protein metabolism of the brain. VI. Cerebral compartments of glutamic acid metabolism. J Neurochem. 1961;7:186-197.
13. Berl S, Takagaki G, Clarke DD, et al. Metabolic compartments in vivo. Ammonia and glutamic acid metabolism in brain and liver. J Biol Chem. 1962;237:2562-2569.
14. Gottlieb M, Wang Y, Teichberg VI. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem. 2003;87:119-126.
15. Zlotnik A, Gruenbaum SE, Artru AA, et al. The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate. J Neurosurg Anesthesiol. 2009;21:235-241.
16. Zlotnik A, Gurevich B, Cherniavsky E, et al. The contribution of the blood glutamate scavenging activity of pyruvate to its neuro-protective properties in a rat model of closed head injury. Neuro-chem Res. 2008;33:1044-1050.
17. Zlotnik A, Gurevich B, Tkachov S, et al. Brain neuroprotection by scavenging blood glutamate. Exp Neurol. 2007;203:213-220.
18. Boyko M, Zlotnik A, Gruenbaum BF, et al. Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke. Eur J Neurosci. 2011;34:1432-1441.
19. Boyko M, Melamed I, Gruenbaum BF, et al. The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage. Neuro-therapeutics. 2012;9:649-657.
20. Zlotnik A, Klin Y, Gruenbaum BF, et al. Beta2 adrenergic-mediated reduction of blood glutamate levels and improved neurological outcome after traumatic brain injury in rats. J Neurosurg Anesthesiol. 2012;24:30-38.
21. Rogachev B, Ohayon S, Saad A, et al. The effects of hemodialysis on blood glutamate levels in chronic renal failure: Implementation for neuroprotection. J Crit Care. 2012;27:743.e1-e7.
22. Twardowski ZJ, Nolph KO, Khanna R, et al. Peritoneal equilibrationtest. Perit Dial Int. 1987;7:138-148.
23. Graham LT Jr., Aprison MH. Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods. Anal Biochem. 1966;15:487-497.
24. Hediger MA, Welbourne TC. Introduction: glutamate transport, metabolism, and physiological responses. Am J Physiol. 1999;277: F477-F480.
25. Soupart A, Silver S, Schrooeder B, et al. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. JAm Soc Nephrol. 2002;13:1433-1441.
26. McLaggan D, Naprstek J, Buurman ET, et al. Interdependence of K+ and glutamate accumulation during osmotic adaptation of Escherichia coli. J Biol Chem. 1994;269:1911-1917.
27. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383-386.
28. Nagy D, Knapp L, Marosi M, et al. Effects of blood glutamate scavenging on cortical evoked potentials. Cell Mol Neurobiol. 2010;30:1101-1106.
29. Leibowitz A, Boyko M, Shapira Y, et al. Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci. 2012;13:10041-10066.